CHRISTUS Health Cancer Center in Longview, which is set to open later this year, named Steven J. DiBiase as their new medical director on Monday. DiBiase previously ...

A new report from free-market policy group Unleash Prosperity argues that curing cancer would deliver a staggering $185 trillion boost to the U.S. economy over 35 years.

IMforte shows lurbinectedin plus atezolizumab maintenance extends PFS and OS in extensive-stage SCLC, with manageable cytopenias and key patient-selection guidance.

As previously presented, gedatolisib + palbociclib + fulvestrant ('gedatolisib triplet”) and gedatolisib + fulvestrant ('gedatolisib doublet”) reduced the risk of disease progression or death versus ...

The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced. The company also said it is ...

A new study analyzing data from more than 1.8 million people found that vegetarians had significantly lower risks of five types of cancers compared to meat eaters.

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

Cancer Clinician and Translational Scientist Dr. Daniela Matei will become the next director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center following a national search, Houston Methodist ...

This article originally published at WTNH anchor Lisa Carberg to depart from station for Yale Cancer Center: 'Truly been a pleasure'.

The University of Oklahoma’s Native Nations Center for Tribal Policy Research has released a new Sovereign Report examining ...

In 992 patients, giredestrant plus palbociclib did not significantly improve investigator-assessed PFS versus letrozole plus ...

Data show that sentinel lymph node biopsy is becoming less routine for older women with breast early stage HR-positive, HER2-negative breast cancer.